These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36581143)

  • 1. Barriers to uptake of Open-Source automated insulin delivery Systems: Analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from the OPEN survey.
    O'Donnell S; Cooper D; Chen Y; Ballhausen H; Lewis DM; Froment T; Anna Gajewska K; Tappe A; Skinner T; Cleal B; Braune K
    Diabetes Res Clin Pract; 2023 Mar; 197():110235. PubMed ID: 36581143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey.
    Huhndt A; Chen Y; O'Donnell S; Cooper D; Ballhausen H; Gajewska KA; Froment T; Wäldchen M; Lewis DM; Raile K; Skinner TC; Braune K
    Front Clin Diabetes Healthc; 2022; 3():876511. PubMed ID: 36992765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.
    Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B
    J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children's Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems.
    Crabtree TSJ; Choudhary P; Lumb A; Hammond P; McLay A; Campbell F; Ng SM; Wilmot EG; Hussain S
    Diabetes Ther; 2022 Feb; 13(2):341-353. PubMed ID: 35099784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial Outcomes Among Users and Nonusers of Open-Source Automated Insulin Delivery Systems: Multinational Survey of Adults With Type 1 Diabetes.
    Schipp J; Hendrieckx C; Braune K; Knoll C; O'Donnell S; Ballhausen H; Cleal B; Wäldchen M; Lewis DM; Gajewska KA; Skinner TC; Speight J
    J Med Internet Res; 2023 Dec; 25():e44002. PubMed ID: 38096018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.
    Lewis DM; Hussain S
    Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning challenges of healthcare professionals supporting open-source automated insulin delivery.
    Crocket H; Lewis DM; Burnside M; Faherty A; Wheeler B; Frewen C; Lever C; Jefferies C; Williman J; Sanders O; Wilson R; Paul R; Price S; Jones S; de Bock M
    Diabet Med; 2022 May; 39(5):e14750. PubMed ID: 34826158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and psychological well-being among children and adolescents with diabetes and their caregivers using open-source automated insulin delivery systems: Findings from a multinational survey.
    Knoll C; Schipp J; O'Donnell S; Wäldchen M; Ballhausen H; Cleal B; Gajewska KA; Raile K; Skinner T; Braune K
    Diabetes Res Clin Pract; 2023 Feb; 196():110153. PubMed ID: 36423699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Adults with Type 1 Diabetes Are Navigating the Challenges of Open-Source Artificial Pancreas Systems: A Qualitative Study.
    Schipp J; Skinner T; Holloway E; Scibilia R; Langstrup H; Speight J; Hendrieckx C
    Diabetes Technol Ther; 2021 Aug; 23(8):546-554. PubMed ID: 33720767
    [No Abstract]   [Full Text] [Related]  

  • 10. A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes.
    Morrison AE; Chong K; Senior PA; Lam A
    PLoS One; 2022; 17(8):e0271096. PubMed ID: 35951597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine.
    Burnside M; Crocket H; Mayo M; Pickering J; Tappe A; de Bock M
    J Diabetes Sci Technol; 2020 Sep; 14(5):878-882. PubMed ID: 31876179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes Management.
    Forlenza GP; Tabatabai I; Lewis DM
    Diabetes Technol Ther; 2024 Oct; 26(10):689-699. PubMed ID: 38669472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-source automated insulin delivery systems and formal healthcare: A qualitative study of challenges in the interaction between service-users with type 1 diabetes and healthcare professionals.
    Raimond LH; O'Donnell S; Bøggild-Damkvist T; Filges T; Lomborg K
    Chronic Illn; 2023 Dec; 19(4):836-847. PubMed ID: 36437583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Care Provider Knowledge and Perceptions of FDA-Approved and Do-It-Yourself Automated Insulin Delivery.
    Murray JA; Clayton MF; Litchman ML
    J Diabetes Sci Technol; 2020 Nov; 14(6):1017-1021. PubMed ID: 31876176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emotional and Physical Health Impact in Children and Adolescents and Their Caregivers Using Open-source Automated Insulin Delivery: Qualitative Analysis of Lived Experiences.
    Braune K; Krug N; Knoll C; Ballhausen H; Thieffry A; Chen Y; O'Donnell S; Raile K; Cleal B
    J Med Internet Res; 2022 Jul; 24(7):e37120. PubMed ID: 35834298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interviews with Indigenous Māori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trial.
    Burnside M; Haitana T; Crocket H; Lewis D; Meier R; Sanders O; Jefferies C; Faherty A; Paul R; Lever C; Price S; Frewen C; Jones S; Gunn T; Wheeler BJ; Pitama S; de Bock M; Lacey C
    J Diabetes Metab Disord; 2023 Jun; 22(1):861-871. PubMed ID: 37250371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'We're all on the same team'. Perspectives on the future of artificial pancreas systems by adults in Australia with type 1 diabetes using open-source technologies: A qualitative study.
    Schipp J; Skinner TC; Holloway E; Scibilia R; Langstrup H; Speight J; Hendrieckx C
    Diabet Med; 2022 May; 39(5):e14708. PubMed ID: 34599617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes.
    Tanenbaum ML; Commissariat PV
    Curr Diab Rep; 2022 Jul; 22(7):291-299. PubMed ID: 35522355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.
    Jennings P; Hussain S
    J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.